InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Cochran Jennifer R., Director. Director active across 2 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 14 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €211k. Activity tracked since 12 July 2021. The latest transaction was filed on 15 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
20,000 sharesCommon StockSEC:0001872349-26-000002:0
20,000 sharesCommon StockSEC:0001872349-25-000004:0
30,000 shares@ US$1.5219.3% of flowCommon StockSEC:0001628280-25-025856:0
Ideal exit: 9 Feb 2026 (T+270)
1,896 sharesCommon StockSEC:0001846253-24-000065:0
20,000 sharesCommon StockSEC:0001846253-24-000052:0
25,518 sharesCommon StockSEC:0001846253-24-000011:0
1,896 sharesCommon StockSEC:0001846253-23-000088:0
17,506 shares0Common StockSEC:0001846253-23-000010:0
22,250 shares@ US$3.75437.6% of flowCommon StockSEC:0000899243-22-038003:0
Ideal exit: 2 Sept 2023 (T+270)
30,000 shares@ US$3.097643.1% of flowCommon StockSEC:0000899243-22-035694:0
Ideal exit: 8 Aug 2023 (T+270)
1,004 sharesCommon StockSEC:0000899243-22-035044:0
25,226 sharesCommon StockSEC:0000899243-22-035066:0
1,004 shares0Common StockSEC:0000886163-22-000083:0
1,161 shares0Common StockSEC:0000886163-21-000108:0
14 of 14 declarations
About Cochran Jennifer R.
Jennifer R. Cochran serves as a Director at LIGAND PHARMACEUTICALS INC. She is involved in corporate governance and strategic decision-making. Her experience in the pharmaceutical sector is valuable in guiding growth and innovation initiatives.
